MORE►
McKesson Corp.
McKesson CEO Brian Tyler [Photo: McKesson]
Eyeing Ophthalmology in $850M Deal, Irving’s McKesson To Snag Controlling Interest in PRISM Vision Holdings
by Lance Murray | Feb 4, 2025
McKesson said it will acquire an 80% interest in the provider of general ophthalmology and retina management services. PRISM Vision physicians will continue to retain a 20% interest in their company.
by Lance Murray |
Oct 1, 2024
McKesson said that with a scalable, flexible suite of services and an experienced leadership team, InspiroGene enables manufacturers, payers, and providers to navigate the complex CGT commercialization landscape—ensuring that "patients can access the life-changing treatments they need."
MORE►
by Lance Murray |
Aug 26, 2024
Florida-based Core Ventures was established by the Florida Cancer Specialists & Research Institute, a physician-owned community oncology practice. With the multi-billion-dollar acquisition, CORE Ventures will join McKesson's US Oncology Network to advance "affordable cancer care and better patient outcomes."
MORE►
by Lance Murray |
Jun 22, 2023
Foster & Thrive unifies McKesson's private brand portfolio—consolidating Health Mart and Sunmark branded OTC products— and aims to offer greater availability through increased production and efficiencies to help meet evolving patient needs and growing demand.
MORE►
![From left: Calvin Carter, Derek Wilson, and Bob Bennett, the founders of Dallas Opportunity Partners, a new Dallas-based investment platform. [Photo: Michael Samples]](https://s24806.pcdn.co/wp-content/uploads/2025/03/DallasOpportunityPartners-970_MNS5714-fullsize.jpg)
